Triad Rx, Inc., Daphne, AL

Is Triad Rx, Inc. registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Triad Rx, Inc. hold a Alabama pharmacy license?

State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search. The Texas State Board of Pharmacy also lists nonresident license 35934 for TRIAD RX, DAPHNE, AL, status Active, as of Nov 15, 2026. The California State Board of Pharmacy also lists nonresident license NRP 3112 for Triad Rx, Daphne, AL, status Active, as of Nov 6, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054017922 for TRIAD RX INC, DAPHNE, AL, status CHANGE OF OWNERSHIP, license 054022073 for TRIAD RX INC, DAPHNE, AL, status NOT RENEWED and license 054022975 for TRIAD RX INC, DAPHNE, AL, status NOT RENEWED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002354 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0013280 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Active, license A9-0012903 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Expired and license A9-0013097 for TRIAD RX BUYER LLC (dba TRIAD RX), DAPHNE, AL, status Closed, as of Nov 10, 2026.

Has Triad Rx, Inc. had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Feb 5, 2019), 1 warning letter close-out (May 3, 2023), 1 state referral letter (May 3, 2023) and 1 FMD-145 letter (May 3, 2023) for Triad Rx, Inc. State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Triad Rx, Inc.
Location
Daphne, AL
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
1
Latest action on that page
May 3, 2023
FDA Data Dashboard inspections
2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
Form 483 text on this page
2 Form 483s, 10 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Triad Rx, Inc., a 503A facility, with 5 dated actions.

Document
May 3, 2023State referral letterState Referral Letter Issued 5/3/2023FDA copy (archived)
May 3, 2023Warning letter close-outWarning Letter Close Out Issued 05/03/2023FDA copy (archived)
May 3, 2023FMD-145 letterFMD-145 Letter Issued 05/03/2023Not linked by FDA
Dec 8, 2022Form 483483 Issued 12/08/2022FDA copy (archived)
Feb 5, 2019Warning letterWarning Letter (02/05/2019)fda.gov

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Triad Rx, Inc, Daphne, AL (FEI number 3013497126), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Dec 8, 2022Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Monitoring of Marketed Animal Drugs, Feed, and Devices (Veterinary): Voluntary Action Indicated (VAI)30134971261192322
Jul 21, 2017Official Action Indicated (OAI)Drug Quality Assurance (Drugs)30134971261018905

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483s for this site have 10 numbered observations in all, across 2 inspections ending Jul 21, 2017 to Dec 8, 2022. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Dec 5, 2022 to Dec 8, 2022: 1 observation

Firm on the cover
Triad Rx, Inc, 26258 Pollard Rd, Daphne, AL 36526-4250
FEI number
3013497126
Establishment type on the cover
Non-Sterile Drug Producer
FDA district office on the cover
60 Eighth Street NE Atlanta, GA 30309
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You produced hazardous drugs without providing adequate cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.

Specifically, there is no deactivating agent used to clean work surfaces, utensils and <Redacted B4> in between production of different hazardous drug products. Hazardous drug products produced include but are not limited to, BI-EST 50:50 (Estriol/Estradiol) in Moisturizing Lotion 5% (50mg/ml) Cream, BI-EST 50:50 (Estriol/ Estradiol)/Pregnenolone 1.5mg/60mg per ml Cream, and BI-EST 50:50 (Estriol/Estradiol)/Progest/Testo/7-K-DHEA/Pregnen 0.25mg/35mg/0. 75mg/10mg/3mg per 0.5ml Cream.

Inspection Jul 17, 2017 to Jul 21, 2017: 9 observations

Firm on the cover
Triad Rx, Inc., 26258 Pollard Road, Daphne, Al 36526
FEI number
3013497126
Establishment type on the cover
Producer of Sterile and Non-sterile Drugs
FDA district office on the cover
404 BNA Dr., Bldg. 200, Ste. 500 Nashville, TN 37217-2597
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

Cleaning pads or wipes used in the ISO 5 area are not sterile.

Specifically, the <Redacted B4> wipers used to clean the ISO 5 area are not sterile.

Observation 2

The ISO-classified areas have difficult to clean, particle-generating, or visibly dirty equipment or surfaces.

Specifically, a lyophilizer and a portable dehumidifier are located in the clean room (ISO 7) adjacent to the ISO 5 area.

Observation 3

Inadequately or un-protected product intended to be sterile was observed to be exposed to lower than ISO 5 quality air.

Specifically, drug products intended to be lyophilized are <Redacted B4> in the ISO 5 area, partially stoppered, and then transferred to the lyophilizer (ISO 7 area) via unprotected/uncovered trays.

Observation 4

Personnel were observed touching equipment or other surfaces located outside ofthe ISO 5 area with gloved hands and then proceeding with aseptic processing without changing or sanitizing gloves.

Specifically, on 07/17/2017, I observed clean room operator, with initials <Redacted B6> perform aseptic processing in the ISO 5 area. The operator did not always disinfect or change gloves before reentering the ISO 5 area after retrieving materials or discarding waste in the ISO 7 area. The following lots were produced without adequate glove disinfection/changes:

- Sermorelin Acetate 9mg/GHRP-2 9mg Lyophililzed, lot 07172017@25

SEE '™"-OYU(lll NAMI: AND Tm.E (1'tW ot Type}

- Sermorelin Acetate 3mg/GHRP-6-3mg, Lyophilized, lot 07172017@24

Observation 5

Personnel engaged in aseptic processing were observed with exposed hands, wrists, legs, hair, or mouth.

Specifically, on 07/117/2017, I observed clean room operator, with initials <Redacted B6> enter the ISO 5 area with bare hands then put on sterile gloves and proceed with aseptic processing. The following lots were produced:

Sermorelin Acetate 9mg/GHRP-2 9mg Lyophilized, lot 07172017@25

Sermorelin Acetate 3mg/GHRP-6 3mg, Lyophilized, lot 07172017@24

Observation 6

Equipment, materials, and/or supplies are not disinfected prior to entering the aseptic processing areas.

Specifically, on 07/1712017, I observed clean room operator, with initials <Redacted B6> move a <Redacted B4> from the ISO 7 area to the ISO 5 area without first disinfecting the equipment.

Observation 7

Personnel were observed conducting aseptic manipulations or placing equipment/supplies in an area that blocked the movement of first pass air around an open unit, whether before or after it is filled with sterile product.

Specifically, on 07/117/2017, I observed clean room operator, with initials <Redacted B6> place hands and arms over open glass vials during aseptic filling of the following products:

Sermorelin Acetate 9mg/GHRP-2 9mg Lyophilized, lot 07172017@25

Sermorelin Acetate 3mg/GHRP-6 3mg, Lyophilized, lot 07172017@24

Observation 8

Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.

Specifically, your firm uses a prepared bleach water solution that consists of <Redacted B4> mixed with <Redacted B4> . However, your firm has not established an effective contact time for this concentration/strength and the contact time is not currently monitored by your firm.

Observation 9

The use of sporicidal agents in the cleanrooms and/or ISO 5 area is inadequate or infrequent.

State board of pharmacy records

State board of pharmacy records for Alabama are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).

LicenseType as the board gives itName on the board recordLocationStatusPrior disciplinary orders (file flag)
35934Non-Resident (Not Located in Texas)TRIAD RXDAPHNE, ALActiveNo

California State Board of Pharmacy, file dated Nov 6, 2026 (California).

LicenseType as the board gives itName on the board recordLocationStatus
NRP 3112Non Resident PharmacyTriad RxDaphne, ALActive

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054017922LICENSED PHARMACYTRIAD RX INCDAPHNE, ALCHANGE OF OWNERSHIP
054022073LICENSED PHARMACYTRIAD RX INCDAPHNE, ALNOT RENEWED
054022975LICENSED PHARMACYTRIAD RX INCDAPHNE, ALNOT RENEWED

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0002354NONRESIDENT PHARMACYTRIAD RX BUYER LLC (dba TRIAD RX)DAPHNE, ALACTIVE (CURRENT)

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0013280Non Resident PharmacyTRIAD RX BUYER LLC (dba TRIAD RX)DAPHNE, ALActive
A9-0012903Non Resident PharmacyTRIAD RX BUYER LLC (dba TRIAD RX)DAPHNE, ALExpired
A9-0013097Non Resident PharmacyTRIAD RX BUYER LLC (dba TRIAD RX)DAPHNE, ALClosed

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.